LAKESHORE ACQUISITION I CORP.
{{company.company_channel.channel_name}}
{{company.company_name_local}}
{{company.company_channel.channel_name}}
Lakeshore Acquisition Corp I Shareholders Approve Business Combination with ProSomnus 2022-12-03 05:05
ProSomnus® Sleep Technologies Announces Signing of Definitive Agreements for $30 Million of Convertible Notes 2022-08-27 04:30
ProSomnus® to Present Data at SLEEP 2022, the Annual Meeting of the American Academy of Sleep Medicine and the Sleep Research Society 2022-06-03 20:00
ProSomnus®, Leader in Patient-Preferred Sleep Apnea Therapy, to be Listed on Nasdaq Through Business Combination with Lakeshore Acquisition I Corp. 2022-05-10 20:00
Lakeshore Acquisition II Corp. Announces that Ordinary Shares, Rights and Warrants to Commence Separate Trading on or about April 14, 2022 2022-04-12 04:15
Lakeshore Acquisition II Corp. Announces Closing of $69 Million Initial Public Offering 2022-03-12 00:50
Lakeshore Acquisition II Corp. Announces Pricing of $60 Million Initial Public Offering 2022-03-09 09:00
Lakeshore Acquisition I Corp. Announces the Separate Trading of its Ordinary Shares and Warrants, Commencing July 22, 2021 2021-07-12 20:00
Lakeshore Acquisition I Corp. Announces Closing of $50 Million Initial Public Offering 2021-06-16 04:30
Lakeshore Acquisition I Corp. Announces Pricing of $50 Million Initial Public Offering 2021-06-11 06:30
1